High intrinsic CD73/adenosine signaling in the tumor microenvironment may also restrain radiotherapy-induced antitumor immune responses and thereby limit the efficacy of combined radio-immunotherapies (Vaupel and Multhoff, 2016; Wennerberg et al., 2017). This evidence concerns the gene NT5E and neoplasm.